Yoshino, Morihiko

Publishing since 1965 (Dinosaur)

Has published 233 publications in 46 years

Number of publications published per year by Yoshino, Morihiko. (Source : PubMed)

Distribution of publications types for Yoshino, Morihiko. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Suzuki M, Wada H, Yoshino M, Tian L, Shigematsu H, Suzuki H, Alaa M, Tamura H, Fujiwara T, Nagato K, Motohashi S, Moriya Y, Hoshino H, Yoshida S, Shibuya K, Hiroshima K, Nakatani Y, Yoshino I. Molecular characterization of chronic obstructive pulmonary disease-related non-small cell lung cancer through aberrant methylation and alterations of EGFR signaling.  Annals of surgical oncology  2010;17;3  
•  Suwa A, Yoshino M, Yamazaki C, Naitou M, Fujikawa R, Matsumoto S, Kurama T, Shimokawa T, Aramori I. RMI1 deficiency in mice protects from diet and genetic-induced obesity.  FEBS J.  2010;277;3  
•  Narumi S, Numakura C, Shiihara T, Seiwa C, Nozaki Y, Yamagata T, Momoi MY, Watanabe Y, Yoshino M, Matsuishi T, Nishi E, Kawame H, Akahane T, Nishimura G, Emi M, Hasegawa T. Various types of LRP5 mutations in four patients with osteoporosis-pseudoglioma syndrome: identification of a 7.2-kb microdeletion using oligonucleotide tiling microarray.  Am. J. Med. Genet. A  2010;152A;1  
•  Morita A, Yamamoto S, Wang B, Tanaka K, Suzuki N, Aoki S, Ito A, Nanao T, Ohya S, Yoshino M, Zhu J, Enomoto A, Matsumoto Y, Funatsu O, Hosoi Y, Ikekita M. Sodium orthovanadate inhibits p53-mediated apoptosis.  Cancer Res.  2010;70;1  
•  Yoshino M, Watanabe Y, Ohira T, Harada N. [Phenylketonuria--toward a better carry-over care]  Nippon Rinsho  2010;68;1  
•  Numata S, Koda Y, Ihara K, Sawada T, Okano Y, Matsuura T, Endo F, Yoo HW, Arranz JA, Rubio V, Wermuth B, Ah Mew N, Tuchman M, Pinner JR, Kirk EP, Yoshino M. Mutant alleles associated with late-onset ornithine transcarbamylase deficiency in male patients have recurrently arisen and have been retained in some populations.  J. Hum. Genet.  2010;55;1  
•  Yoshino M, Suzuki M, Tian L, Moriya Y, Hoshino H, Okamoto T, Yoshida S, Shibuya K, Yoshino I. Promoter hypermethylation of the p16 and Wif-1 genes as an independent prognostic marker in stage IA non-small cell lung cancers.  Int. J. Oncol.  2009;35;5  
•  Yoshida S, Kurokohchi K, Ueno T, Yoshino M, Shimada M, Masaki T. Hepatic von Meyenburg complex: a trigger of severe portal hypertension.  Liver Int.  2009;29;4  
•  Alaa M, Suzuki M, Yoshino M, Tian L, Suzuki H, Nagato K, Fujiwara T, Wada H, Moriya Y, Hoshino H, Motohashi S, Yoshida S, Shibuya K, Hiroshima K, Nakatani Y, Abdrabou A, Elkholy M, Mahfouz T, Yoshino I. Prostaglandin E2 receptor 2 overexpression in squamous cell carcinoma of the lung correlates with p16INK4A methylation and an unfavorable prognosis.  Int. J. Oncol.  2009;34;3  
•  Otomo T, Muramatsu T, Yorifuji T, Okuyama T, Nakabayashi H, Fukao T, Ohura T, Yoshino M, Tanaka A, Okamoto N, Inui K, Ozono K, Sakai N. Mucolipidosis II and III alpha/beta: mutation analysis of 40 Japanese patients showed genotype-phenotype correlation.  J. Hum. Genet.  2009;54;3  

[ See timeline ] [ See all publications ]